EXUMA Biotech Corp. filed a Form D with the Securities and Exchange Commission on 2026-08-20.
EXUMA Biotech Corp. filed a Form D notice of an exempt securities offering with the SEC on August 20, 2026. The filing reports $70M sold. Its industry group is Biotechnology. It names Gregory Frost (Chairman and Chief Executive Officer), David Ramsay (Director), Daniel Flynn (Director) (SEC Form D, August 20, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to EXUMA Biotech Corp.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like EXUMA Biotech Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns EXUMA Biotech Corp.
Free to see. No signup.
More on the people and the money behind EXUMA Biotech Corp., from the filings we hold.
Biotechnology raises by companies based in Florida, filed in August 2026, largest first.
Get an email when EXUMA Biotech Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when EXUMA Biotech Corp. raises, hires or launches. No email unless you switch it on.
Watch EXUMA Biotech Corp. →Get the full cited report on EXUMA Biotech Corp.
What the filing shows about EXUMA Biotech Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on EXUMA Biotech Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives EXUMA Biotech Corp.'s address as 625 N. Flagler Drive, Suite 625, West Palm Beach, FL 33401.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
EXUMA Biotech Corp. is a registered filer with the SEC (CIK 1698021) and has filed since 2026-08-20. 1 filing is on record, the latest on 2026-08-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
EXUMA Biotech Corp.'s Form D of 2026-08-20 names Gregory Frost, David Ramsay, Daniel Flynn and 3 more as its officers, directors or promoters.
Its new offerings report $70M sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $70M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Gregory Frost is named as Chairman and Chief Executive Officer on the Form D that EXUMA Biotech Corp. filed with the SEC on 20 August 2026, one of 6 people that filing names.
David Ramsay is named as Director on the Form D that EXUMA Biotech Corp. filed with the SEC on 20 August 2026, one of 6 people that filing names.
Daniel Flynn is named as Director on the Form D that EXUMA Biotech Corp. filed with the SEC on 20 August 2026, one of 6 people that filing names.
Houston Holmes is named as Director on the Form D that EXUMA Biotech Corp. filed with the SEC on 20 August 2026, one of 6 people that filing names.
Frank McCormick is named as Director on the Form D that EXUMA Biotech Corp. filed with the SEC on 20 August 2026, one of 6 people that filing names.
On the filing as: Executive Officer.
Richard Yan is named as Principal Accounting Officer on the Form D that EXUMA Biotech Corp. filed with the SEC on 20 August 2026, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2026-08-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about EXUMA Biotech Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on EXUMA Biotech Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on EXUMA Biotech Corp. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist EXUMA Biotech Corp.You get an alert in MentionFox the next time this company shows up.
If you're behind EXUMA Biotech Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (exumabio.com).
Each opens in a new tab, filled in for EXUMA Biotech Corp.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-08-17 · Biotech raises in Miami
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/exuma-biotech-corp-form-d-26000001